Refresh

Indrayani Biotech Ltd. - Research Center

526445 INDRANIB Group (XT) BSE data
Back to Company

Results

Statement

More

Balance Sheet
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Sources of funds
Owner's fund

Equity share capital

34.23 34.23 34.23 3.64 3.64

Share application money

- - - 30.58 -

Preference share capital

9.25 - - - -

Reserves & surplus

7.67 -10.05 -14.28 -3.39 -4.30
Loan funds

Secured loans

35.27 9.95 7.28 6.80 -

Unsecured loans

- 6.79 8.15 6.94 0.64

Total

86.42 40.91 35.38 44.58 -0.01
Uses of funds
Fixed assets

Gross block

23.81 15.33 15.11 17.36 -

Less : revaluation reserve

- - - - -

Less : accumulated depreciation

- - - - -

Net block

23.81 15.33 15.11 17.36 -

Capital work-in-progress

12.72 13.22 13.72 13.59 -

Investments

7.99 0.19 0.19 0.01 -
Net current assets

Current assets, loans & advances

55.79 20.70 10.83 20.50 0.01

Less : current liabilities & provisions

13.88 8.53 4.47 6.90 0.02

Total net current assets

41.91 12.18 6.37 13.61 -0.01

Miscellaneous expenses not written

- - - - -

Total

86.42 40.91 35.38 44.58 -0.01
Notes:

Book value of unquoted investments

7.99 0.19 - - -

Market value of quoted investments

- - - - -

Contingent liabilities

- - - - -

Number of equity sharesoutstanding (Lacs)

342.27 342.27 342.27 36.44 36.44
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com